GRANULES

Granules India Ltd. is a leading manufacturer of active pharmaceutical ingredients (API) and pharmaceutical formulations. The company was founded in 1989 and is headquartered in Hyderabad, India. Granules has a strong presence in the global market, with clients including major pharmaceutical companies such as Pfizer, GlaxoSmithKline, and Sanofi. Growth Prospects Granules has a strong pipeline of API and pharmaceutical formulations, which are expected to drive growth in the coming years. The company has also established partnerships with major pharmaceutical companies, including Pfizer and Sanofi, to supply APIs and formulations globally. Final View We believe that Granules India Ltd. is an attractive investment opportunity due to its strong financial performance, growing pipeline, and expanding global presence. However, investors should note that the company faces intense competition in the API market, which may impact its profitability in the short term.